UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ewing’s sarcoma of the larynx: Effective treatment with organ preservation

Strahlentherapie und Onkologie, 2013-07, Vol.189 (7), p.586-589

2013

Volltextzugriff (PDF)

Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer

Strahlentherapie und Onkologie, 2013-10, Vol.189 (10), p.861-866

2013

Volltextzugriff (PDF)

PO-0668: Tumor volume as an essential prognostic factor for radiotherapy outcome in patients with early laryngeal cancer

Radiotherapy and oncology, 2013-03, Vol.106, p.S256-S256

2013

Volltextzugriff (PDF)

The Role of Biochemical Markers in Prediction of Radiation Therapy Failure for Patients With Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S710-S710

2012

Volltextzugriff (PDF)

PO-102: Prognostic Value of Osteopontin and C-Reactive Protein for Patients with Head and Neck Cancer

Radiotherapy and oncology, 2013-02, Vol.106, p.S43-S43

2013

Volltextzugriff (PDF)

DWI ADC AS A PREDICTIVE FACTOR OF THE RESPONSE TO RADIOCHEMOTHERAPY IN HEAD AND NECK CANCER

Radiotherapy and oncology, 2011, Vol.98, p.S45-S45

2011

Volltextzugriff (PDF)

DIFFUSION-WEIGHTED MR IMAGING APPLICATION IN EVALUATION OF RESPONSE TO TREATMENT OF HEAD AND NECK REGION CANCER

Radiotherapy and oncology, 2011, Vol.98, p.S37-S37

2011

Volltextzugriff (PDF)

EP-1204 MARKERS OF TREATMENT OUTCOME FOR PATIENTS WITH HEAD AND NECK CANCER WHO UNDERWENT RADIOTHERAPY

Radiotherapy and oncology, 2012-05, Vol.103, p.S463-S463

2012

Volltextzugriff (PDF)

Predictors of radiotherapy outcome in patients with T2 supraglottic carcinoma

European archives of oto-rhino-laryngology, 2012-03, Vol.269 (3), p.923-929

2012

Volltextzugriff (PDF)

A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation

Journal of thrombosis and haemostasis, 2004-01, Vol.2 (1), p.47-53

2004

Volltextzugriff (PDF)

290. Trudności w diagnostyce obrazowej chorych na nowotwory masywu szczękowositowego i podstawy czaszki leczonych w sposób skojarzony z rekonstrukcją chirurgiczną

Reports of practical oncology and radiotherapy, 2003, Vol.8, p.S334-S334

2003

Volltextzugriff (PDF)

88/Ocena ryzyka popromiennej osteoporozy kręgosłupa szyjnego u chorych na raka rejonu głowy i szyi – doniesienie wstępne

Reports of practical oncology and radiotherapy, 2004, Vol.9, p.S309-S309

2004

Volltextzugriff (PDF)

281. Ocena ryzyka przerzutów odległych u chorych leczonych na mięsaki tkanek miękkich w Instytucie Onkologii w Gliwicach w latach 1991–2001

Reports of practical oncology and radiotherapy, 2003, Vol.8, p.S329-S329

2003

Volltextzugriff (PDF)

1674P VILP registry of patients with metastatic pancreatic cancer treated with pegylated liposomal irinotecan plus 5-fluoroucil and leucovorin in the Czech Republic

Annals of oncology, 2023-10, Vol.34, p.S919-S919

2023

Volltextzugriff (PDF)

BETWEEN ZERO AND INFINITY: SELECTED PROJECTS IN ARCHITECTURE

Illumina ARTbibliographies Modern - unstructured, 1981

1981

Volltextzugriff (PDF)

Abstract P4-21-12: Preference of trastuzumab administration route (intravenous or subcutaneous) in patients in the Czech Republic. Cross-sectional study on 429 patients

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-21-12

2017

Volltextzugriff (PDF)

Abstract P5-21-31: Treatment patterns and outcomes of pertuzumab in combination with trastuzumab and docetaxel as first-line treatment of metastatic HER-2 positive breast cancer : Comparison of Czech clinical registry and CLEOPATRA trial data

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-21-31

2018

Volltextzugriff (PDF)

PD-033Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii114-ii115

2016

Volltextzugriff (PDF)

P-153Regorafenib in the real-life clinical practice: data from the czech registry

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii45-ii45

2016

Volltextzugriff (PDF)

Diagnosing COPD: advances in training and practice - a systematic review

Advances in medical education and practice, 2016-01, Vol.7 (Issue 1), p.219-231

2016

Volltextzugriff (PDF)

RICHARD MEIER ARCHITECT

Illumina ARTbibliographies Modern - unstructured, 1984

1984

Volltextzugriff (PDF)

2615 Efficacy and tolerability of axitinib in metastatic renal cell carcinoma (mRCC): Comparison of Czech clinical registry and AXIS trial data

European journal of cancer (1990), 2015-09, Vol.51, p.S516-S516

2015

Volltextzugriff (PDF)

Czech multicenter research database of severe COPD

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9 (default), p.1265-1274

2014

Volltextzugriff (PDF)

Comparison of survival for left-sided KRASwt mCRC patients treated with anti-EGFR based therapy as compared to right-sided mCRC

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.763-763

2017

Volltextzugriff (PDF)

168O Right-sided versus left-sided primary tumor location in patients with KRASmut metastatic colorectal cancer (mCRC) treated with 1st-line anti-VEGF plus chemotherapy (CTx) - Data from the National Czech Registry

Annals of oncology, 2016-12, Vol.27, p.ix53-ix53

2016

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Ewing’s sarcoma of the larynx: Effective treatment with organ preservation

Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer

PO-0668: Tumor volume as an essential prognostic factor for radiotherapy outcome in patients with early laryngeal cancer

The Role of Biochemical Markers in Prediction of Radiation Therapy Failure for Patients With Head-and-Neck Cancer

PO-102: Prognostic Value of Osteopontin and C-Reactive Protein for Patients with Head and Neck Cancer

DWI ADC AS A PREDICTIVE FACTOR OF THE RESPONSE TO RADIOCHEMOTHERAPY IN HEAD AND NECK CANCER

DIFFUSION-WEIGHTED MR IMAGING APPLICATION IN EVALUATION OF RESPONSE TO TREATMENT OF HEAD AND NECK REGION CANCER

EP-1204 MARKERS OF TREATMENT OUTCOME FOR PATIENTS WITH HEAD AND NECK CANCER WHO UNDERWENT RADIOTHERAPY

Predictors of radiotherapy outcome in patients with T2 supraglottic carcinoma

A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation

290. Trudności w diagnostyce obrazowej chorych na nowotwory masywu szczękowositowego i podstawy czaszki leczonych w sposób skojarzony z rekonstrukcją chirurgiczną

88/Ocena ryzyka popromiennej osteoporozy kręgosłupa szyjnego u chorych na raka rejonu głowy i szyi – doniesienie wstępne

281. Ocena ryzyka przerzutów odległych u chorych leczonych na mięsaki tkanek miękkich w Instytucie Onkologii w Gliwicach w latach 1991–2001

1674P VILP registry of patients with metastatic pancreatic cancer treated with pegylated liposomal irinotecan plus 5-fluoroucil and leucovorin in the Czech Republic

BETWEEN ZERO AND INFINITY: SELECTED PROJECTS IN ARCHITECTURE

Abstract P4-21-12: Preference of trastuzumab administration route (intravenous or subcutaneous) in patients in the Czech Republic. Cross-sectional study on 429 patients

Abstract P5-21-31: Treatment patterns and outcomes of pertuzumab in combination with trastuzumab and docetaxel as first-line treatment of metastatic HER-2 positive breast cancer : Comparison of Czech clinical registry and CLEOPATRA trial data

PD-033Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

P-153Regorafenib in the real-life clinical practice: data from the czech registry

Diagnosing COPD: advances in training and practice - a systematic review

RICHARD MEIER ARCHITECT

2615 Efficacy and tolerability of axitinib in metastatic renal cell carcinoma (mRCC): Comparison of Czech clinical registry and AXIS trial data

Czech multicenter research database of severe COPD

Comparison of survival for left-sided KRASwt mCRC patients treated with anti-EGFR based therapy as compared to right-sided mCRC

168O Right-sided versus left-sided primary tumor location in patients with KRASmut metastatic colorectal cancer (mCRC) treated with 1st-line anti-VEGF plus chemotherapy (CTx) - Data from the National Czech Registry

Suchergebnisse filtern